Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-10 8:34 pm Unchanged | 13G | Acrivon Therapeutics Inc. ACRV | Chione Ltd | 3,848,632 12.500% | 0 (Unchanged) | View |
| 2024-07-10 8:29 pm Sale | 13G | Acrivon Therapeutics Inc. ACRV | Chione Ltd | 3,848,632 17.300% | -7,965 (-0.21%) | View |
| 2023-02-14 3:41 pm Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd | 4,400,000 3.900% | -600,000 (-12.00%) | View |
| 2022-11-28 3:59 pm Purchase | 13G | Acrivon Therapeutics Inc. ACRV | Chione Ltd | 3,856,597 18.500% | 3,856,597 (New Position) | View |
| 2022-02-11 2:54 pm Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd | 5,000,000 6.600% | -500,000 (-9.09%) | View |
| 2021-07-26 5:19 pm Purchase | 13D | SERA PROGNOSTICS INC. SERA | Chione Ltd | 1,980,350 6.800% | 1,980,350 (New Position) | View |
| 2021-02-16 4:03 pm Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd | 5,500,000 7.500% | -195,499 (-3.43%) | View |
| 2020-02-14 3:31 pm Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd | 5,695,499 9.100% | -1,935,768 (-25.37%) | View |